Parathyroid hormone is a type of hormone secreted by the parathyroid glands. Parathyroid glands are located behind the thyroid in the back of the neck and are responsible for remodeling of the bone. Parathyroid hormones maintain the calcium level between the range of 9.0 to 10.1 in the blood. Any imbalance in these hormones can cause serious illnesses, which can be overcome by using the parathyroid hormone drug that maintain the calcium level in bones and blood. There are three type of parathyroid hormones: primary, secondary and tertiary. In primary and tertiary hyperparathyroidism, the level of calcium increases in the blood due to irregular secretion of the parathyroid hormone. In secondary hyperparathyroidism, the calcium level is low due to other factors, such as kidney malfunction, etc.
Request Sample report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2582
Hypocalcemia, hypoparathyroidism and osteoporosis are some of the medical conditions associated with parathyroid hormone. Hypocalcemia is a condition mostly observed in neonatal in which calcium ions in the blood become low. In hypoparathyroidism, phosphorous and calcium metabolism get disturbed due to deficiency of the parathyroid hormone. In osteoporosis, the bone density lowers down and bone tissues get thinner. The main factor driving the growth of the global parathyroid hormone market is increasing rate of drug abuse, smoking and alcohol consumption. All of these cause a variety of health problems and imbalance in body hormones. Moreover, unhealthy diet and lifestyle are also affecting human health and affecting the level of calcium, phosphorus and other chemical elements in human body. Altogether, these factors will push the growth of the global parathyroid hormone market during the forecast period.
Parathyroid Hormone Market: Regional Outlook
Geographically, the global market is segmented into viz. North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market and will be followed by Europe due to increased healthcare spending and stringent rules and regulations regarding drug usage. Asia Pacific excluding Japan is expected to grow at the highest CAGR during the forecast period and is projected to be a profitable market for new and emerging market players. Latin America and the Middle East and Africa regions are estimated to show sluggish growth over the forecast period.
Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=2582
Parathyroid Hormone Market: Drivers and Restraints
The parathyroid hormone market will register robust growth, primarily due to increasing incidences of hypocalcemia and hypoparathyroidism during the forecast period. Additionally, the growing ageing population will also boost the demand for parathyroid hormones to fight chances of osteoporosis. However, delay in FDA and regulatory approval for drugs might restrain the growth of the market during the forecast period. Also, vitamin D and calcium allergies will lead to the growth of the parathyroid hormone market as healthcare professionals often suggest vitamin D supplements to patients having hypocalcemia. Vitamin D supplements absorb calcium from the body of hypocalcemia patients.
Parathyroid Hormone Market: Overview
Parathyroid hormone is responsible for calcium absorption and vitamin D metabolism in the body. This hormone also reduces calcium loss in urine. The hormone also stimulates the formation of active vitamin D in kidneys. Hence, this hormone plays a very important role in maintaining calcium and Vitamin D balance in the body. Health problems and drug addiction can affect calcium ratio in the body. Moreover, increasing steroid and supplements consumption also affect the level of parathyroid hormone in the body. All of these factors will push the growth of the global market during the forecast period.
Parathyroid Hormone Market: Key Players
Examples of some of the key players operating in the global parathyroid hormone market are Shire plc, Eli Lilly and Company, Abbott Laboratories, Pfizer, Smith & Nephew plc, Amgen Inc., Novo Nordisk, Novartis,, Ethicon, Inc., Mylan Laboratories, Zimmer Biomet Holdings, Inc. and others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Overview @ https://www.factmr.com/report/2582/parathyroid-hormone-market
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
